Award
75A50325F80009
View source record on USAspending.gov ↗DOXYCYCLINE HYCLATE 100 MG ORAL TABLETS
- Recipient
- CHARTWELL RX LLC
- Awarding agency
- Department of Health and Human Services
- Sub-agency
- Office of Assistant Secretary for Preparedness and Response
- Fiscal year
- FY2025
- Obligated (promised)
- $98,684,252
- Total obligation (detail)
- $98,684,252
- Potential value (ceiling)
- $167,964,526
- Outlaid (paid out, linked File C)
- no linked financial data
- Signed
- Jun 18, 2025
- Period of performance
- Jun 23, 2025 – Jan 4, 2027
- Competition
- FULL AND OPEN COMPETITION
- Offers received
- 2
- Solicitation
- SUBJECT TO MULTIPLE AWARD FAIR OPPORTUNITY
- Pricing
- FIRM FIXED PRICE
- NAICS
- 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING
- Award type
- DELIVERY ORDER
Transactions (3)
| 0 | Jun 18, 2025 | — | $41,014,272 | DOXYCYCLINE HYCLATE 100 MG ORAL TABLETS |
| P00001 | Aug 12, 2025 | EXERCISE AN OPTION | $57,669,980 | EXERCISE OPTIONAL ORDERING PERIOD YEAR 2 DOXYCYCLINE HYCLATE 100 MG ORAL TABLETS |
| P00002 | Dec 12, 2025 | SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | $0 | MODIFICATION TO UPDATE THE PERIOD OF PERFORMANCE ON ORDERING PERIOD 2. |
Record history in our archive
Outlay keeps a content-hashed copy of this record from every pull. No post-publication revisions observed so far.
- detailfirst capture